Thats why we begin with a full assessment of your health history, lifestyle, and goals
GLP-1 receptor agonists slow gastric emptying and intestinal transit as part of their mechanism of action, which can lead to constipation in more than 1 in 10 people taking higher doses for weight management
Meanwhile, patients are filing lawsuits against well-known GLP-1 brands such as Ozempic/Wegovy, Saxenda, and Mounjaro
However, it remains uncertain whether these observations reflect direct modulation of aging-related mitochondrial decline or secondary improvements resulting from restored metabolic homeostasis
Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial
Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment